Olga Sukocheva
Royal Adelaide Hospital, SA Health Department for Health and Wellbeing, State University of New York, State University of Uzbekistan, Flinders University
Research areas: Biochemistry, Genetics and Molecular Biology · Molecular Biology · Sphingolipid Metabolism and Signaling · Estrogen and related hormone effects · Cancer, Lipids, and Metabolism
0000-0003-1041-3311
About
After completion Ph.D. in Biophysics (1997), Dr Sukocheva was awarded Muskie Fellowship in 1999 and had an opportunity to get Masters in Public Health (MPH) at State University of New York (SUNY at Albany, NY) and work as a Postdoctoral Scientist at the New York State Department of Health, Wadsworth Laboratories. Dr Sukocheva worked as grant funded scientist with Professor David O. Carpenter in the area of Environmental toxins/Cancer Research under NYS Government Superfund scheme.
In 2000 Sukocheva was granted Australian permanent residence status and was appointed as a postdoctoral research scientist at Hanson Cancer Research Institute (SA Pathology, Division of Human Immunology). In 2010 Sukocheva was awarded CME Kelly Cancer Research Fellowship at Flinders University and joined Professor David I. Watson oesophageal cancer group. Dr Sukocheva was also appointed as Lecturer in Health Sciences at the Flinders University College of Nursing and Health Sciences (2015-2021).
During COVID-19 pandemia, Dr Sukocheva joined the COVID Operation team at SA Health where she worked as Public Health Officer for 2 years. Dr Sukocheva worked as part-time Lecturer at the University of Adelaide, teaching social public health topic to medical students (2023).
Currently, Dr Sukocheva is appointed as Scientist at Royal Adelaide Hospital (SA Health), Department of Gastroenterology and Hepatology, clinical trials group.
Dr Olga Sukocheva is interested in identifying mechanisms that govern liver-related metabolic pathologies, development of drug resistance, and cancer immune evasion. She aims to identify markers and potential therapeutic targets against gastrointestinal/liver cancers. Dr Sukocheva is also interested in fatty-liver pathologies/cancer genetics and liver disease epidemiology, metabolism-related health complications, and clinical data analysis.
Employment
-
Royal Adelaide Hospital Scientist2022 - Present
-
SA Health Department for Health and Wellbeing Senior Public Health Officer2021 - 2023
-
Flinders University Lecturer in Health Sciences2015 - 2023
-
Flinders University Scientist2010 - 2015
-
Institute of Medical and Veterinary Sciences scientist2002 - 2010
-
New York State Department of Health scientist1999 - 2001
Education
-
State University of New York Master1999 - 2001
-
State University of Uzbekistan PhD1993 - 1997
Projects & Funding
-
Cytotoxic cytokines resistance in breast cancer cells: role of Sphingosine -1-phosphate receptors Lyn Wrigley Breast Cancer Research & Development Fund, Flinders Foundation2013 - 2014
-
The role of oestrogen receptor signalling in oesophageal adenocarcinoma Cancer Council South Australia2012 - 2013
-
CME Kelly Cancer Research Fellowship CME Kelly Cancer Research Fund at Flinders University and Flinders Medical Centre2010 - 2014
Publications (71)
- Development of Neuroprotective Agents for the Treatment of Alzheimer's Disease using Conjugates of Serotonin with Sesquiterpene Lactones Save
- Histone Deacetylase Inhibitors as Cognitive Enhancers and Modifiers of Mood and Behavior Save
- Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy Save
- Corrigendum to “Mitochondrial mutations and mitoepigenetics Save
- Nanomedicines: Targeting inflammatory pathway in cancer and aging Save
- Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome Save
- Development of antibody resistance in emerging mutant strains of SARS CoV-2 Save
- Mitochondrial mutations and mitoepigenetics Save
- Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders. Save
- Advances in the Prevention and Treatment of Obesity-Driven Effects in Breast Cancers Save
- Perspectives of using microRNA-loaded nanocarriers for epigenetic reprogramming of drug resistant colorectal cancers. Save
- Antibody responses and CNS pathophysiology of Mucormycosis in Chronic SARS CoV-2 infection: Current Therapies against Mucormycosis Save
- Recent Investigations on Neurotransmitters’ Role in Acute White Matter Injury of Perinatal Glia and Pharmacotherapies—Glia Dynamics in Stem Cell Therapy Save
- Influence of RNA interference of phytochrome A1 gene on activity of antioxidant system in cotton Save
- Long-lasting post-COVID-19 sequelae and its overlap with ME/CSF Save
- Novel Multitarget Hydroxamic Acids with a Natural Origin CAP Group against Alzheimer’s Disease: Synthesis, Docking and Biological Evaluation Save
- Increased Sensitivity of Detection of RASSF1A and GSTP1 DNA Fragments in Serum of Prostate Cancer Patients: Optimisation of Diagnostics Using OBBPA-ddPCR Save
- Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo Save
- Stereotactic Ablative Brachytherapy: Recent Advances in Optimization of Radiobiological Cancer Therapy Save
- Divergence of Intracellular Trafficking of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Receptor 3 in MCF-7 Breast Cancer Cells and MCF-7-Derived Stem Cell-Enriched Mammospheres Save